Journals / Journal of Clinical and Analytical Medicine / 2012 / Cilt: 3 - Sayı: 1

Yeni kardiyovasküler risk faktörleri; istirahat kalp hızı, Hs-CRP, fibrinojen ve PMNL

New cardiovascular risk factors; resting heart rate, Hs-CRP, fibrinogen and PMNL

Pages
68–71
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were statistically significant differences between the patient group and the control group regarding systolic and diastolic blood pressure, leukocyte count, hs-CRP and fibrinogen levels and resting heart rates (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study we aimed to evaluate the possibility of a presence of an association between the high resting heart rate and micro inflammatory response and with the help of any found, clarify the recently identified negative cardiovascular prognosis in individuals with high resting heart rate from an etiological point of view.
📊
Key Findings & Data:Material and Method: Study was conducted in September, 2009 with a total of 67 male cases consisting of 36 cases that are followed up at Haseki Egt. ve Ars.
💡
Conclusion & Impact:There were statistically significant differences between the patient group and the control group regarding systolic and diastolic blood pressure, leukocyte count, hs-CRP and fibrinogen levels and resting heart rates (p
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In this study we aimed to evaluate the possibility of a presence of an association between the high resting heart rate and micro inflammatory response and with the help of any found, clarify the recently identified negative cardiovascular prognosis in individuals with high resting heart rate from an etiological point of view. Material and Method: Study was conducted in September, 2009 with a total of 67 male cases consisting of 36 cases that are followed up at Haseki Egt. ve Ars. Hospital Cardiology Outpatient and Coronary Intensive Care Clinic and 31 cases included in the control group. Patient and control groups were compared regarding age, body mass index, systolic and diastolic blood pressure, leukocyte count, hs-CRP and fibrinogen levels, coronary risk factors and resting heart rates. Result: Significant difference was seen between resting heart rate, smoking and positive family history. There were statistically significant differences between the patient group and the control group regarding systolic and diastolic blood pressure, leukocyte count, hs-CRP and fibrinogen levels and resting heart rates (p

Özet

Amaç: Bu çalışmada, yüksek dinlenme kalp hızının mikroinflamatuvar cevapla bir ilişkisi olması ihtimalini değerlendirmek ve olası bir ilişkilendirme yardımıyla istirahat kalp hızı artmış bireylerde yakın zamanda tanımlanmış olumsuz kardiyovasküler prognozu etyolojik yönden daha fazla açığa kavuşturmayı hedefledik. Gereç ve Yöntem: Çalışmaya Eylül 2008 ve Mart 2009 Tarihleri arasında Haseki Eğitim ve Araştırma Hastanesi Kardiyoloji Polikliniğinde ve Koroner Yoğun Bakımında takibi yapılmış olan 36 hasta ve 31 kişilik kontrol grubu ile beraber toplam 67 erkek hasta dahil edildi. Hasta grup ve kontrol grubu yaş, beden kitle indeksi, sistolik ve diyastolik kan basıncı, lökosit sayısı, hs-CRP ve fibrinojen düzeyleri, koroner risk faktörleri ve istirahat kalp hızı ayrı ayrı karşılaştırıldı. Bulgular: İstirahat kalp hızı ile sigara ve aile öyküsü arasında anlamlı fark görüldü. Hasta gruptaki sistolik kan basıncı, diyastolik kan basıncı, istirahat kalp hızı, lökosit sayısı, Hs-CRP ve fibrinojen düzeyleri ile; sağlıklı gruptaki düzeyleri karşılaştırıldığında; gruplar arasında istatistiksel olarak çok ileri düzeyde anlamlı farklılık bulundu (p

🔖

Cite This Article

AKTUĞLU, M. B., KUMBASAR, A., BELİBAĞLI, M. C., ÇİLİNGİR, H. (2022). Yeni kardiyovasküler risk faktörleri; istirahat kalp hızı, Hs-CRP, fibrinojen ve PMNL. Journal of Clinical and Analytical Medicine, Cilt: 3 - Sayı: 1, 68–71. https://ajindex.com/articles/561357

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Mutangadura, Gladys B editors. Reducing risks, promoting healthy life World Health Report 2002:.
  2. Geneva, World Health Organization, 2002 2. Dr. Sadi Güleç. Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2009:37 (Suppl.2):S1-10. 3. Kannel WB. Range of serum cholesterol values in the poulation developing coronary artery disease.Am J Cardiol 1995;76:69-77. 4. Chait A, Han CY, Oram JF, Heinecke JW. Thematic rewiew series:The immune system and atherogenesis.lipoprotein-associated inflammatory proteins: Marker sor mediators of cardiovascular disease? J Lipid Res 2005;46:389-403 5. Willerson JT, Ridker PM. İnflammation as a cardiovascular risk factor versus risk factor. Circulation 2004:109 (21 Suppl 1):p2-10 6. Li JJ, Fang CH. C-reactive protein is not only an inflamatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 2004;62:499-506. 7. Palatini P. Heart Rate: a strong predictor of mortality in subjects with coronary artery disease. Eur Heart J 2005;26:943-5 8. Bere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosklerosis.Science 1984;226:180-2. 9. Assmann G, Schulte H, Funke H, Von Eckardstein A. The emergence of triglyserides as a significiant independent risk factor in coronary artery disease. Eur Heart J. 1998:19 (suppl M): M8-M14. 10. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999 Sep 7;100(10):1134-1146. 11. Giuliani A, Mitterhammer H, Burda A, Egger G, Glasner A. Polymorphonuclear leucocyte function during the menstrual cycle and during controlled ovarian hyperstimulation. Fertil Steril 2004;82:1711. 12. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494. 13. Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC. Resting heart rate: a modifiable prognostic indicatorof cardiovascular risk and outcomes? Can J Cardiol. 2008 May;24 (Suppl A):3A-8A 14. Singh BN. İncreased heart rate as a risk factor for cardiovascular disease. Eur Heart J Suppl 2003;5 (Suppl G):G3-G9. 15. Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S,et al. Heart rate and microinflamation in men:a relevant atherothrombotic link.Heart 2007;93: 940-944. 16. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rat